Loading clinical trials...

TERMINATEDNANCT01528072

Dynesys Spinal System Post Market 522 Study

The purpose of this study is to assess the safety and fusion rates following posterior lateral fusion with the Dynesys Spinal System used as an adjunct to fusion and compare to literature control.

Lead sponsor: Zimmer Biomet•9 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 4

Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery

NCT05029726 · Lumbar Spinal Stenosis, Lumbar Disc Herniation, and more

Enrolling By Invitation

Lumbar Interbody Implant Study

NCT04418830 · Degenerative Disc Disease, Degenerative Spondylolisthesis, and more

Enrolling By Invitation

Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion

NCT06000319 · Degenerative Disc Disease, Degenerative Spondylolisthesis, and more

Active Not RecruitingNA

LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosis

NCT03115983 · Degenerative Spondylolisthesis, Lumbar Spinal Stenosis

Active Not Recruiting

The NORDSTEN Studies/The Observational Cohort Study

NCT03562936 · Degenerative Lumbar Spinal Stenosis, Degenerative Spondylolisthesis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 29, 2020Terms

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment153

Start dateMar 2012

Last updatedJan 29, 2020

Condition

Degenerative Spondylolisthesis Pseudoarthrosis

Locations shown

Neurological Surgery of Southern Ill

Belleville, Illinois

Greater Baltimore Medical Center

Baltimore, Maryland

Pine Heights Medical Center

Baltimore, Maryland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 29, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions